Peptides & Peptide Synthesis Products


TBTU, Catalog No: 31011
O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate, CAS: 125700-67-6, MW: 321.08, Formula: C11H16BF4N5O
Catalog No: 31011
O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate, CAS: 125700-67-6, MW: 321.08, Formula: C11H16BF4N5O


O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate
Additional Information

Additional Information

Catalog Number 31011
CAS 125700-67-6
M.W. 321.08
Formula C11H16BF4N5O
IUPAC Name [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium tetrafluoroborate
Synonym O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate
Also Known As
  • (benzotriazol-1-yloxy-dimethylaminomethylidene)-dimethylazanium tetrafluoroborate
  • (benzotriazol-1-yloxy-dimethylamino-methylene)-dimethyl-ammonium tetrafluoroborate
  • (1-benzotriazolyloxy-dimethylaminomethylene)-dimethylammonium tetrafluoroborate
  • (benzotriazol-1-yloxy-dimethylamino-methylidene)-dimethyl-azanium tetrafluoroborate
  • O-(Benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
  • TBTU
  • 385522_ALDRICH
  • 12806_FLUKA
  • N,N,N′,N′-Tetramethyl-O-(benzotriazol-1-yl)uronium tetrafluoroborate
InChI InChI=1S/C11H16N5O.BF4/c1-14(2)11(15(3)4)17-16-10-8-6-5-7-9(10)12-13-16;2-1(3,4)5/h5-8H,1-4H3;/q+1;-1
SMILES [B-](F)(F)(F)F.CN(C)C(=[N+](C)C)ON1C2=CC=CC=C2N=N1
Cited Uses


1. Lakshman MK et al, "Facile synthesis of 1-alkoxy-1H-benzo- and 7-azabenzotriazoles from peptide coupling agents, mechanistic studies, and synthetic applications", Beilstein Journal of Organic Chemistry, 10() pp.1919-1932 ().
2. Xiao X et al, "Paper Synthesis, Cytotoxicity and Apoptosis Induction in Human Tumor Cells by Galaxamide and Its Analogues", Marine Drugs, 12(8) pp.4521-4538 ().
3. Liu Y et al, "Synthesis and Analgesic Effects of ?-TRTX-Hhn1b on Models of Inflammatory and Neuropathic Pain", Toxins, 6(8) pp.2363-2378 ().
4. Kopka K et al, "Pharmaceuticals--Special Issue on Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy", Pharmaceuticals, 7(7) pp.839-849 ().
5. Jida M et al, "One-Pot Isomerization-Cross Metathesis-Reduction (ICMR) Synthesis of Lipophilic Tetrapeptides", ACS combinatorial science, 16(7) pp.342-351 (2014 Jul 14).
6. Fischer CA et al, "A Bombesin-Shepherdin Radioconjugate Designed for Combined Extra- and Intracellular Targeting", Pharmaceuticals, 7(6) pp.662-675 ().
7. M├Ąde V et al, "Automated solid-phase peptide synthesis to obtain therapeutic peptides", Beilstein Journal of Organic Chemistry, 10() pp.1197-1212 ().
8. Abramova TV et al, "Solid-phase-supported synthesis of morpholinoglycine oligonucleotide mimics", Beilstein Journal of Organic Chemistry, 10() pp.1151-1158 ().
9. Ballet S et al, "In Vitro Membrane Permeation Studies and in Vivo Antinociception of Glycosylated Dmt1-DALDA Analogues", ACS medicinal chemistry letters, 5(4) pp.352-357 ().
10. Nagel D et al, "Polymeric Microspheres as Protein Transduction Reagents", Molecular & Cellular Proteomics : MCP, 13(6) pp.1543-1551 (2014 Jun).
11. Koopmanschap G et al, "Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics", Beilstein Journal of Organic Chemistry, 10() pp.544-598 ().
12. Zidar N et al, "Antimicrobial Activity of the Marine Alkaloids, Clathrodin and Oroidin, and Their Synthetic Analogues", Marine Drugs, 12(2) pp.940-963 ().
13. Sousa CA et al, "New L-Serine Derivative Ligands as Cocatalysts for Diels-Alder Reaction", ISRN organic chemistry, 2013() pp.217675 ().
14. Pesic A et al, "Champacyclin, a New Cyclic Octapeptide from Streptomyces Strain C42 Isolated from the Baltic Sea", Marine Drugs, 11(12) pp.4834-4857 ().
15. Herce HD et al, "Visualization and targeted disruption of protein interactions in living cells", Nature Communications, 4() pp.2660 ().
16. Qiang X et al, "Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsis", Nature medicine, 19(11) pp.10.1038/nm.3368 (2013 Nov).
17. Hampton SE et al, "Investigation of acyclic uridine amide and 5?-amido nucleoside analogues as potential inhibitors of the Plasmodium falciparum dUTPase", Bioorganic & Medicinal Chemistry, 21(18) pp.5876-5885 (2013 Sep 15).
18. Zhang Y et al, "Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity", Chemical biology & drug design, 82(2) pp.125-130 (2013 Aug).
19. Bengtsson C et al, "Asymmetric Synthesis of 2,4,5-Trisubstituted ?2-Thiazolines", Chemistry (Weinheim an Der Bergstrasse, Germany), 19(30) pp.9916-9922 (2013 Jul 22).
20. Kumar B et al, "Dynamics of Physical Interaction between HIV-1 Nef and ASK1: Identifying the Interacting Motif(S)", PLoS ONE, 8(6) pp.e67586 ().
21. Chapman TM et al, "Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1)", Bioorganic & Medicinal Chemistry Letters, 23(10) pp.3064-3069 (2013 May 15).
22. Jones S et al, "Intracellular translocation and differential accumulation of cell-penetrating peptides in bovine spermatozoa: evaluation of efficient delivery vectors that do not compromise human sperm motility", Human Reproduction (Oxford, England), 28(7) pp.1874-1889 (2013 Jul).
23. Kumar EA et al, "The paradox of conformational constraint in the design of Cbl(TKB)-binding peptides", Scientific Reports, 3() pp.1639 ().
24. Vicente EF et al, "Dynamics and Conformational Studies of TOAC Spin Labeled Analogues of Ctx(Ile21)-Ha Peptide from Hypsiboas albopunctatus", PLoS ONE, 8(4) pp.e60818 ().
25. Scott D et al, "Semi-synthetic Mithramycin SA Derivatives with Improved Anti-Cancer Activity", Chemical biology & drug design, 81(5) pp.615-624 (2013 May).